83 related articles for article (PubMed ID: 38636522)
1. Single-Cell Analysis Unveils the Role of the Tumor Immune Microenvironment and Notch Signaling in Dormant Minimal Residual Disease.
Janghorban M; Yang Y; Zhao N; Hamor C; Nguyen TM; Zhang XH; Rosen JM
Cancer Res; 2022 Mar; 82(5):885-899. PubMed ID: 34965936
[TBL] [Abstract][Full Text] [Related]
2. Anti-Jagged-1 immunotherapy in cancer.
Pancewicz J; Niklinska W; Eljaszewicz A
Adv Med Sci; 2022 Sep; 67(2):196-202. PubMed ID: 35421813
[TBL] [Abstract][Full Text] [Related]
3. Precision medicine for human cancers with Notch signaling dysregulation (Review).
Katoh M; Katoh M
Int J Mol Med; 2020 Feb; 45(2):279-297. PubMed ID: 31894255
[TBL] [Abstract][Full Text] [Related]
4. Jagged2 targeting in lung cancer activates anti-tumor immunity via Notch-induced functional reprogramming of tumor-associated macrophages.
Mandula JK; Sierra-Mondragon RA; Jimenez RV; Chang D; Mohamed E; Chang S; Vazquez-Martinez JA; Cao Y; Anadon CM; Lee SB; Das S; Rocha-Munguba L; Pham VM; Li R; Tarhini AA; Furqan M; Dalton W; Churchman M; Moran-Segura CM; Nguyen J; Perez B; Kojetin DJ; Obermayer A; Yu X; Chen A; Shaw TI; Conejo-Garcia JR; Rodriguez PC
Immunity; 2024 May; 57(5):1124-1140.e9. PubMed ID: 38636522
[TBL] [Abstract][Full Text] [Related]
5. Determinant roles of dendritic cell-expressed Notch Delta-like and Jagged ligands on anti-tumor T cell immunity.
Tchekneva EE; Goruganthu MUL; Uzhachenko RV; Thomas PL; Antonucci A; Chekneva I; Koenig M; Piao L; Akhter A; de Aquino MTP; Ranganathan P; Long N; Magliery T; Valujskikh A; Evans JV; Arasada RR; Massion PP; Carbone DP; Shanker A; Dikov MM
J Immunother Cancer; 2019 Apr; 7(1):95. PubMed ID: 30940183
[TBL] [Abstract][Full Text] [Related]
6. Distinct biological roles for the notch ligands Jagged-1 and Jagged-2.
Choi K; Ahn YH; Gibbons DL; Tran HT; Creighton CJ; Girard L; Minna JD; Qin FX; Kurie JM
J Biol Chem; 2009 Jun; 284(26):17766-74. PubMed ID: 19398556
[TBL] [Abstract][Full Text] [Related]
7. Notch signaling triggered via the ligand DLL4 impedes M2 macrophage differentiation and promotes their apoptosis.
Pagie S; Gérard N; Charreau B
Cell Commun Signal; 2018 Jan; 16(1):4. PubMed ID: 29321062
[TBL] [Abstract][Full Text] [Related]
8. Notch ligands are biomarkers of anti-TNF response in RA patients.
Zack SR; Meyer A; Zanotti B; Volin MV; Deen S; Satoeya N; Sweiss N; Lewis MJ; Pitzalis C; Kitajewski JK; Shahrara S
Angiogenesis; 2024 May; 27(2):273-283. PubMed ID: 37796367
[TBL] [Abstract][Full Text] [Related]
9. Jagged2 progressively increased expression from Stage I to III of Bladder Cancer and Melatonin-mediated downregulation of Notch/Jagged2 suppresses the Bladder Tumorigenesis
Chen YT; Huang CR; Chang CL; Chiang JY; Luo CW; Chen HH; Yip HK
Int J Biol Sci; 2020; 16(14):2648-2662. PubMed ID: 32792862
[No Abstract] [Full Text] [Related]
10. Myeloid cell-targeted therapies for solid tumours.
Goswami S; Anandhan S; Raychaudhuri D; Sharma P
Nat Rev Immunol; 2023 Feb; 23(2):106-120. PubMed ID: 35697799
[TBL] [Abstract][Full Text] [Related]
11. Tumor-derived Jagged1 promotes cancer progression through immune evasion.
Meng J; Jiang YZ; Zhao S; Tao Y; Zhang T; Wang X; Zhang Y; Sun K; Yuan M; Chen J; Wei Y; Lan X; Chen M; David CJ; Chang Z; Guo X; Pan D; Chen M; Shao ZM; Kang Y; Zheng H
Cell Rep; 2022 Mar; 38(10):110492. PubMed ID: 35263601
[TBL] [Abstract][Full Text] [Related]
12. JASPAR 2022: the 9th release of the open-access database of transcription factor binding profiles.
Castro-Mondragon JA; Riudavets-Puig R; Rauluseviciute I; Lemma RB; Turchi L; Blanc-Mathieu R; Lucas J; Boddie P; Khan A; Manosalva Pérez N; Fornes O; Leung TY; Aguirre A; Hammal F; Schmelter D; Baranasic D; Ballester B; Sandelin A; Lenhard B; Vandepoele K; Wasserman WW; Parcy F; Mathelier A
Nucleic Acids Res; 2022 Jan; 50(D1):D165-D173. PubMed ID: 34850907
[TBL] [Abstract][Full Text] [Related]
13. Interferon Regulatory Factor 4 Regulates the Development of Polymorphonuclear Myeloid-Derived Suppressor Cells Through the Transcription of c-Myc in Cancer.
Yang Q; Xie H; Li X; Feng Y; Xie S; Qu J; Xie A; Zhu Y; Zhou L; Yang J; Hu X; Wei H; Qiu H; Qin W; Huang J
Front Immunol; 2021; 12():627072. PubMed ID: 33708218
[TBL] [Abstract][Full Text] [Related]
14. Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity.
Veglia F; Sanseviero E; Gabrilovich DI
Nat Rev Immunol; 2021 Aug; 21(8):485-498. PubMed ID: 33526920
[TBL] [Abstract][Full Text] [Related]
15. IRF4 overexpression promotes the transdifferentiation of tregs into macrophage-like cells to inhibit the development of colon cancer.
Wang J; Li S; Li H; Zhou X; Wen H; Lai B
Cancer Cell Int; 2021 Jan; 21(1):58. PubMed ID: 33468159
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
